Beedan 50 mg Dasatinib Tablets (1 pack / 60 tabs)

Buy Beedan 50 mg Dasatinib Tablets Online

Beedan 50 mg Dasatinib Tablets (1 pack / 60 tabs)

At a Glance

Generic Name: Dasatinib

Brand Name: Beedan 50 mg

Strength & Pack Size: 50 mg tablets, 1 pack / 60 tablets

Dosage Form & Route: Oral film-coated tablets taken by mouth

Therapeutic Class: BCR-ABL tyrosine kinase inhibitor (TKI)

Primary Indications: Chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL), as per local label

Typical Use in Therapy: Long-term oral targeted therapy under specialist haematology–oncology supervision

Mode of Action: Inhibits BCR-ABL and related tyrosine kinases to block leukemic cell signalling and proliferation

Key Benefits: Proven efficacy in CML and Ph+ ALL with convenient oral dosing when used appropriately and monitored carefully

Precautions: Requires close monitoring of blood counts, liver function, cardiac status, pleural effusions and drug interactions

Storage: Store below 25 °C in the original blister, protected from moisture and out of reach of children

Product Description

Beedan 50 mg contains dasatinib, an oral BCR-ABL tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) in adults and, in some settings, older children under specialist care. Unlike traditional cytotoxic chemotherapy that indiscriminately targets fast-dividing cells, dasatinib is a targeted therapy designed to block specific signalling pathways that drive leukemic cell growth.

Each pack of Beedan 50 mg dasatinib tablets supplied by Generic Meds Mart contains 60 film-coated tablets, each with 50 mg of dasatinib. The tablets are usually taken once daily, or occasionally in another schedule according to local labels and protocols, with dosing individualised by the treating haematologist based on disease phase, prior therapies, tolerance and response. Because dasatinib can cause clinically significant side effects affecting the blood, lungs, heart and other organs, Beedan 50 mg should never be used without regular specialist follow-up and comprehensive monitoring.

At Generic Meds Mart, Beedan 50 mg dasatinib tablets are sourced only from licensed manufacturers and authorised oncology distributors. Each pack is supplied in its original, sealed blister and carton with visible batch number and expiry date so that hospital pharmacies and clinics can verify the medicine on receipt. Parcels are shipped in neutral outer packaging, without explicit reference to leukemia or targeted therapy, to help preserve patient privacy while maintaining full documentation for medical teams. Our role is to support access and logistics; all clinical decisions about dasatinib dosage, duration and combinations remain with your treating specialists.

Key Uses

Beedan 50 mg dasatinib tablets are used as part of systemic therapy for BCR-ABL–driven leukemias, according to local prescribing information and international guidelines. Typical uses include:

• Treatment of newly diagnosed or previously treated chronic myeloid leukemia (CML) in different phases, where dasatinib is considered an appropriate tyrosine kinase inhibitor option.
• Treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) as part of multi-drug regimens, often combined with chemotherapy or other targeted agents.
• Use in patients who are intolerant of or resistant to other BCR-ABL TKI therapies, where switching to dasatinib is considered clinically appropriate by the haematologist.

The choice to use Beedan 50 mg rather than another TKI depends on disease phase, risk category, prior treatment history, comorbidities, potential for drug interactions and patient-specific factors such as cardiovascular and pulmonary status.

How Dasatinib Works in Chemotherapy

Dasatinib, the active ingredient in Beedan 50 mg, is a potent tyrosine kinase inhibitor that targets the BCR-ABL fusion protein produced by the Philadelphia chromosome abnormality, which is characteristic of most CML cases and many Ph+ ALL cases. The BCR-ABL fusion protein acts as a continuously active kinase, driving uncontrolled proliferation and survival of leukemic cells.

By binding to and inhibiting BCR-ABL, dasatinib interrupts this abnormal signalling, promoting growth arrest and apoptosis (programmed cell death) in leukemic cells that depend on BCR-ABL activity. Dasatinib also inhibits a range of related kinases, including members of the SRC family, which may contribute to its clinical activity in CML and Ph+ ALL. In many patients, consistent dasatinib therapy can induce haematologic, cytogenetic and molecular responses that translate into improved long-term outcomes when treatment is monitored and adjusted appropriately.

Dosage & Administration

Beedan 50 mg dasatinib tablets must be prescribed and monitored by physicians experienced in managing CML and Ph+ ALL. The dose and schedule of dasatinib depend on the indication (CML phase or Ph+ ALL), prior treatment, co-morbidities and concomitant medicines. Tablets are usually taken once daily, with or without food, swallowing them whole with water. Patients are generally advised not to crush, break or chew the tablets.

Certain medicines, particularly strong inhibitors or inducers of CYP3A4 and medicines that significantly alter gastric pH, may interact with dasatinib and require careful management or avoidance. Routine monitoring typically includes full blood counts, liver function tests, assessment for fluid retention and pleural or pericardial effusions, and evaluation of cardiovascular status. Dose adjustments, interruptions or discontinuation may be needed if side effects become problematic or if laboratory markers indicate safety concerns. Patients should follow their specialist’s instructions precisely and should not change the dasatinib dosage on their own.

Precautions

Before starting Beedan 50 mg, the haematology team will evaluate cardiac risk, pulmonary history, bleeding risk, liver and kidney function, concomitant medicines and infection risk. Dasatinib can cause pleural effusions, pulmonary arterial hypertension, fluid retention, thrombocytopenia, neutropenia and bleeding, among other issues, so baseline and ongoing evaluation is essential. Patients with a history of significant heart disease, poorly controlled hypertension or severe lung disease require especially careful assessment and monitoring.

Grapefruit and grapefruit juice are usually discouraged because of interactions with CYP3A4. Because dasatinib can affect platelet function and coagulation, patients should inform medical and dental teams about their treatment before procedures. Effective contraception is generally recommended for people of childbearing potential during dasatinib therapy and for a period after stopping, as dasatinib may harm a developing fetus. Breastfeeding is usually not recommended while taking Beedan 50 mg.

Dasatinib Side Effects

Common side effects

Common dasatinib side effects in patients taking Beedan 50 mg include myelosuppression (low white cells, red cells and platelets), headache, fatigue, nausea, diarrhoea, abdominal discomfort, mild skin rash, joint or muscle pains and fluid retention such as ankle swelling or periorbital puffiness. Many patients also experience mild to moderate infections due to reduced immune reserve. With close monitoring and timely dose adjustments, many of these effects can be managed with supportive care, temporary treatment interruptions or dose modifications.

Serious side effects

Serious dasatinib adverse effects require urgent medical attention and may include severe neutropenia or thrombocytopenia with infections or bleeding, significant pleural effusions or fluid around the lungs, pulmonary arterial hypertension, heart rhythm problems, severe shortness of breath, marked fluid retention, liver injury or gastrointestinal bleeding. Unexplained chest pain, sudden breathlessness, rapid weight gain, confusion, high fever, uncontrollable bleeding or black/tarry stools are all warning signs that demand immediate medical review.

Any new or rapidly worsening symptom while taking Beedan 50 mg dasatinib tablets should be reported promptly to the treating team, and patients should not stop therapy abruptly without specialist advice unless instructed to do so in an emergency.

Storage

Beedan 50 mg tablets should be stored below 25 °C in their original blister inside the outer carton, protected from moisture and direct heat. Tablets should be kept out of sight and reach of children and should not be transferred into unlabelled containers. Medicines must not be used after the expiry date printed on the pack. Unused or expired dasatinib tablets should be returned to a pharmacy or disposed of using an approved medicines disposal route; they should not be thrown into household rubbish or wastewater.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on improving access to essential targeted therapies such as Beedan 50 mg dasatinib tablets for patients with CML and Ph+ ALL. We work only with licensed manufacturers and authorised distributors who follow recognised quality standards and provide full batch traceability. Every pack of Beedan 50 mg is supplied in original, sealed packaging so that your haematology–oncology team and pharmacy can confirm brand, strength, batch number and expiry before dispensing.

Orders are processed in USD through secure checkout, and shipments are placed in discreet, neutral outer boxes without explicit reference to leukemia, dasatinib or cancer medicines. Where available, trackable delivery options help patients and clinics plan refills so that targeted therapy can continue without interruption. Our role is strictly logistical; complex questions about dasatinib dosage, treatment duration, switching to or from other TKIs and combination strategies remain exclusively with your treating specialists.

Order Now

Before you buy Beedan 50 mg online from Generic Meds Mart, you should have a confirmed diagnosis of CML or Ph+ ALL and a clear recommendation from your haematologist or oncologist that dasatinib is the right BCR-ABL inhibitor for your situation. Your team will explain the goals of therapy, planned monitoring, expected time course for response and what to do if side effects occur.

Once this plan is in place, you can select Beedan 50 mg (1 pack / 60 tabs), choose the number of packs that matches your prescription interval and complete secure checkout in USD. Your medicines will be shipped in discreet packaging with appropriate documentation. You should never initiate, adjust or stop dasatinib therapy without specialist guidance, and any worrying symptom during treatment should prompt immediate contact with your medical team. Generic Meds Mart is here to support safe, reliable access to Beedan 50 mg dasatinib tablets while all clinical decisions remain in professional hands.

FAQ about Beedan (Dasatinib)

Q1: What is Beedan 50 mg used for?
Beedan 50 mg contains dasatinib, a BCR-ABL tyrosine kinase inhibitor used under specialist supervision for chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL), according to local prescribing information and guidelines.

Q2: Is Beedan 50 mg chemotherapy?
Beedan 50 mg is considered targeted therapy rather than traditional cytotoxic chemotherapy. It works by blocking BCR-ABL and related kinases that drive leukemic cell growth, but it is still a potent anticancer medicine and must be used with the same level of care and monitoring as other systemic treatments.

Q3: How long will I need to take Beedan 50 mg?
Dasatinib therapy is often long term, especially in CML, and may continue for many years if well tolerated and effective. In Ph+ ALL, treatment duration and the role of dasatinib may differ. Only your haematology team can define how long you should remain on Beedan 50 mg based on your response, side effects and evolving evidence.

Q4: Can I take Beedan 50 mg with my other medicines?
Some medicines, particularly those that strongly affect CYP3A4 or stomach acidity, can interact with dasatinib and alter its levels in the body. You should provide your specialist and pharmacist with a full list of prescription drugs, over-the-counter medicines and supplements so they can check for interactions and adjust therapy where needed.

Q5: What should I do if I miss a dose of Beedan 50 mg?
If you forget a dose, the usual advice is to take the next dose at the regularly scheduled time and not to double up tablets to make up for the missed dose. However, specific instructions can vary, so follow the guidance in your patient leaflet and from your care team, and contact them if you are unsure how to proceed after a missed dose.

Q6: Is Beedan 50 mg the same as Sprycel (Generic Sprycel)?
Beedan 50 mg is Generic Sprycel — it contains the same active ingredient (dasatinib) as Sprycel. It’s used for the same purpose at the same strength, while differences may be in manufacturer, inactive ingredients (excipients), tablet appearance, and packaging. If you’re switching between products, confirm the substitution with a qualified healthcare professional.